-- Fennec Pharmaceuticals Brief: Net loss for the quarter ended March 31, 2023 was US$6.1 million ($0.23 per share), compared to $3.7 million ($0.14 per share) for the same period in 2022

-- Fennec Pharmaceuticals Brief: Net loss for the quarter ended March 31, 2023 was US$6.1 million ($0.23 per share), compared to $3.7 million ($0.14 per share) for the same period in 2022

MT Newswires · 05/11/2023 02:07

Please log in to view news